The Role of Orlistat Combined with Lifestyle Changes in the Management of Overweight and Obese Patients with Polycystic Ovary Syndrome

This 2014 prospective study evaluated the effects of combining orlistat (120 mg three times daily) with lifestyle modifications (low-calorie diet and exercise) over six months in 101 women with PCOS and 29 BMI-matched controls. Both groups experienced significant BMI reductions. In the PCOS group, there were notable improvements in insulin